XTL Biopharmaceuticals Ltd.
XTLB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,027 | -$1,782 | -$1,348 | $435 |
| Dep. & Amort. | $199 | $0 | $1 | $1 |
| Deferred Tax | -$130 | $0 | $487 | $0 |
| Stock-Based Comp. | $264 | $3 | $14 | $37 |
| Change in WC | $189 | $64 | -$19 | -$54 |
| Other Non-Cash | -$1,113 | $1,008 | -$36 | -$1,468 |
| Operating Cash Flow | -$1,618 | -$707 | -$901 | -$1,049 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$54 | $0 | $0 | $0 |
| Net Acquisitions | -$410 | $0 | $0 | $0 |
| Inv. Purchases | -$14 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$366 | $41 | $36 | $8 |
| Investing Cash Flow | -$844 | $41 | $36 | $8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$13 | $0 | $0 | $0 |
| Stock Issued | $1,460 | $0 | $0 | $385 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $1,447 | $0 | $0 | $385 |
| Forex Effect | -$15 | -$27 | -$10 | -$6 |
| Net Chg. in Cash | -$1,030 | -$693 | -$875 | -$662 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,401 | $2,094 | $2,969 | $3,631 |
| End Cash | $371 | $1,401 | $2,094 | $2,969 |
| Free Cash Flow | -$1,672 | -$707 | -$901 | -$1,049 |